Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study

NCT04893031 · clinicaltrials.gov ↗

COMPLETED

Status

213

Enrollment

OTHER

Sponsor class

Conditions

Tocilizumab
COVID-19
Critical Care
Mortality

Interventions

DRUG: Tocilizumab

Sponsor

Karadeniz Technical University